SCS-85056-59106
2 vaccinations
4 coded responses
16 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 895 / NV
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Pfizer-BioNTech
-
2021-02-26
Registered in v-safe
-
2021-02-26
Dose 2 — Pfizer-BioNTech
- 2021-02-26
- 2021-02-27
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · ChillsAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
- 2021-03-02
-
2021-03-03
Survey response — days 1–6 daily, dose 2MedDRA: Upper-airway cough syndrome — Feeling: GoodFree text: A cold with post nasal dripMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-05
Health check-in — day 7, dose 2Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
-
2021-05-30
Survey response — 3 months, dose 2MedDRA: Pharyngitis streptococcal — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Strep throat two weeks agoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-30
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-27
Survey response — 6 months, dose 2MedDRA: Breakthrough COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Breakthrough covid caseMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-27
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-30
-
2021-09-02
Call successfulDoes not wish to fill out VAERS report
-
2022-02-26
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | |
| 2 | 2021-02-26 | Pfizer-BioNTech |
Call center
2 call center cases
2 successful
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): A cold with post nasal drip
Release 8 — 3 months, dose 2
Symptoms: Strep throat two weeks ago
Release 9 — 6 months, dose 2
Symptoms: Breakthrough covid case
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breakthrough COVID-19 | ✓ | · | ✓ |
| SD | Pharyngitis streptococcal | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release